Cohen & Steers, Inc. (CNS)
$
80.25
+1.69 (2.11%)
Key metrics
Financial statements
Free cash flow per share
2.0773
Market cap
4 Billion
Price to sales ratio
7.6214
Debt to equity
0.2758
Current ratio
25.3859
Income quality
0.7818
Average inventory
0
ROE
0.3280
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Cohen & Steers, Inc. is a publicly owned asset management holding company, identified in the market by the symbol 'CNS'. The firm offers its services through subsidiaries to various institutional investors, including pension funds, endowments, and foundations. The company reported depreciation and amortization expenses of $11,169,000.00 reflecting the wear and tear of its assets. It manages client-focused equity, fixed income, multi-asset, and commodity portfolios, showcasing its diverse investment strategies. The weighted average number of shares outstanding is 50,409,000.00 highlighting the company's shareholder base. Additionally, the cost of revenue for the company is $275,117,000.00 which underscores its production and operational expenses. The firm reported selling, general, and administrative expenses of $60,135,000.00 indicating its operational overhead costs. Established in 1986 and based in New York, with additional offices in London, Hong Kong, Tokyo, and Seattle, Cohen & Steers has a global reach, investing in public equity, fixed income, and commodity markets. Through its subsidiaries, it also focuses on companies in the real estate sector, including real estate investment trusts, as well as in the infrastructure and natural energy resources sectors for both equity and fixed income investments, while also investing in preferred securities. The stock is reasonably priced at $78.68 appealing to a broad range of investors. Despite being a key player in the Asset Management industry, contributing significantly to the overall market landscape, it has a low average trading volume of 215,723.00 indicating lower market activity. With a mid-range market capitalization of $4,090,503,000.00 the company stands as a steady performer in the market. Furthermore, it belongs to the Financial Services sector, driving innovation and growth within the industry. This combination of factors positions Cohen & Steers not only as a reliable investment option but also as an influential participant in the asset management landscape, reinforcing its stability and commitment to its investors.
What is Cohen & Steers, Inc. (CNS)'s stock forecast?
Analysts predict Cohen & Steers, Inc. stock to fluctuate between $64.13 (low) and $110.67 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Cohen & Steers, Inc.'s market capitalization?
As of 2025-04-01, Cohen & Steers, Inc.'s market cap is $4,090,503,000, based on 50,972,000 outstanding shares.
How does Cohen & Steers, Inc. compare to competitors like JPMorgan Chase & Co.?
Compared to JPMorgan Chase & Co., Cohen & Steers, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Cohen & Steers, Inc. (CNS) stock?
To buy Cohen & Steers, Inc. (CNS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CNS. Place an order (Market, Limit, etc.).
What is the best time to invest in Cohen & Steers, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Cohen & Steers, Inc. perform in the last earnings report?
Revenue: $517,417,000 | EPS: $3 | Growth: 14.50%.
Where can I find Cohen & Steers, Inc.'s investor relations reports?
Visit https://www.cohenandsteers.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Cohen & Steers, Inc.?
You can explore historical data from here
What is the all-time high and low for Cohen & Steers, Inc. stock?
All-time high: $110.67 (2024-10-17) | All-time low: $50.05 (2023-10-26).
What are the key trends affecting Cohen & Steers, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
benzinga.com
CNS Pharmaceuticals, Inc. CNSP on Tuesday announced the primary analysis of its clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.
globenewswire.com
WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to participate in a fireside chat at the Stifel 2025 Virtual CNS Forum on Tuesday, March 18, 2025 at 4:00 p.m. ET.
prnewswire.com
NEW YORK , March 10, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.6 billion as of February 28, 2025, an increase of $2.1 billion from assets under management of $86.4 billion at January 31, 2025. The increase was due to market appreciation of $2.3 billion, partially offset by distributions of $151 million and net outflows of $16 million.
prnewswire.com
LONDON , March 3, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today the launch of the Cohen & Steers SICAV Short Duration Preferred Income Fund. This is the firm's second fund focused on the preferred securities market available to UCITS investors, in addition to the Cohen & Steers SICAV Preferred Income Fund, launched in 2017.
accessnewswire.com
HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-50 reverse split of its common stock. Beginning on February 21, 2025, the Company's common stock will continue to trade on The Nasdaq Capital Market ("Nasdaq") on a split adjusted basis under the trading symbol "CNSP", but will trade under the following new CUSIP number: 18978H409.
prnewswire.com
NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Index (IRP), effective as of the close of business on February 21, 2025. Cohen & Steers Global Realty Majors Portfolio Index (GRM) Added component (symbol) Removed component (symbol) Hongkong Land Holdings Ltd.
See all news
